Enzo Biochem said this week that it has filed an application with New York State for approval of its first assay based on its new AmpiProbe nucleic acid detection technology.

Enzo is seeking approval from the New York State Department of Health for an HCV RNA quantification assay for hepatitis C viral load detection. If approved, the test would be made available through its Enzo Clinical Laboratory branches.

The company also plans to seek the CE IVD mark for the assay in the European Union.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.